Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ketorolac Dosing for Acute Vaso-Occlusive Crisis in Pediatric Patients With Sickle Cell Disease

NCT06579703 is registered in ClinicalTrials.gov with Children's Blood and Cancer Center at Dell Children's Medical Center as lead sponsor.

NCT NCT06579703
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06579703 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ketorolac Dosing for Acute Vaso-Occlusive Crisis in Pediatric Patients With Sickle Cell Disease
Lead sponsor
Children's Blood and Cancer Center at Dell Children's Medical Center
Phase
Phase 4
Overall status
Not yet recruiting
Start date
September 30, 2024
Completion date
February 15, 2028
Enrollment
102 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell crisis, sickle cell disease, veno-occlusive disease